Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of CS-1008 in Combination With Chemotherapy (Paclitaxel/Carboplatin) in Locally Advanced or Metastatic Ovarian Cancer

NCT00945191 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00945191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00945191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of CS-1008 in Combination With Chemotherapy (Paclitaxel/Carboplatin) in Locally Advanced or Metastatic Ovarian Cancer
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Completed
Start date
October 6, 2009
Completion date
August 23, 2011
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer stage iiic, ovarian cancer stage iv